Recent developments of drug eluting stent coatings

Yaoxue Xuebao

Volumn 46, Issue 11, 2011, Pages 1301-1307

  Chen, Wen Ping ^a   Zhan, Hong Bing ^a  

^a FUZHOU UNIVERSITY   (China)

Author keywords

Drug carrier; Drug release system; Drug targeting; Restenosis; Stent

Indexed keywords

BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG RELEASE; HUMAN; MATERIAL COATING; RESTENOSIS; REVIEW;

BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; LACTIC ACID; PHOSPHORYLCHOLINE; POLYETHYLENES; POLYGLYCOLIC ACID; PROSTHESIS DESIGN; TITANIUM;

EID: 84862929650     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury [J]. Adv Drug Deliv Rev, 2006, 58: 358-376. (Pubitemid 43816739)
2. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty [J]. Eng J Med, 1987, 316: 701-706. (Pubitemid 17036474)
3. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: part I [J]. Circulation, 2002, 106: 2734-2740. (Pubitemid 35364930)
4. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: part I. Evolution of percutaneous coronary intervention [J]. Anesth Analg, 2008, 107: 552-569.
5. Daemen J, Serruys PW. Drug-eluting stent update 2007. Part II: Unsettled issues [J]. Circulation, 2007, 116: 961-968. (Pubitemid 47300921)
6. Ding MH, Li L, Zhang YF. Research progress in drug-loaded coating materials of drug eluting stents and their preparation technology [J]. Mater Rev, 2007, 21: 39-42.
7. Woods TC, Marks AR. Drug-eluting stents [J]. Ann Rev Med, 2004, 55: 169-178. (Pubitemid 38316721)
8. Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents [J]. Adv Drug Deliv Rev, 2006, 58: 387-401. (Pubitemid 43816741)
9. Leon MB, Abizaid A, Moses JW. Subgroup analysis from the Cypher clinical triall // The CYPHER Stent: A New Gold Standard in the Treatment of Coronary Artery Disease [C]. New York: Cardiovascular Research Foundation, 2003: 54-57.
10. Ellis SG, Colombo A, Grube E, et al. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent - A TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years [J]. J Am Coll Cardiol, 2007, 49: 1043-1051. (Pubitemid 46357591)
11. Walter DH, Cejna M, Diaz-Sandoval L, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents - an alternative strategy for inhibition of restenosis [J]. Circulation, 2004, 110: 36-45. (Pubitemid 38885702)
12. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis [J]. Circulation, 2001, 103: 2289-2295. (Pubitemid 32433720)
13. Lansky AJ, Costa RA, Mintz GS, et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions - angiographic follow-up of the DELIVER clinical trial [J]. Circulation, 2004, 109: 1948-1954. (Pubitemid 38544484)
14. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent [J]. Circulation, 2001, 104: 473-479. (Pubitemid 32678280)
15. Bartorelli AL, Trabattoni D, Fabbiocchi F, et al. Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent [J]. J Interv Cardiol, 2003, 16: 499-505. (Pubitemid 37431017)
16. Finkelstein A, Mcclean D, Kar S, et al. Local drug delivery via a coronary stent with programmable release pharmacokinetics [J]. Circulation, 2003, 107: 777-784. (Pubitemid 36222609)
17. Minghetti P, Cilurzo F, Selmin F, et al. Sculptured drug-eluting stent for the on-site delivery of tacrolimus [J]. Eur J Pharm Biopharm, 2009, 73: 331-336.
18. Mani G, Macias CE, Feldman MD, et al. Delivery of paclitaxel from cobalt-chromium alloy surfaces without polymeric carriers [J]. Biomaterials, 2010, 31: 5372-5384.
19. Choi J, Konno T, Takai M. Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface [J]. Biomaterials, 2009, 30: 5201-5208.
20. Chen MC, Tsai HW, Liu CT, et al. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs [J]. Biomaterials, 2009, 30: 2102-2111.
21. Chen MC, Tsai HW, Chang Y, et al. Rapidly self-expandable polymeric stents with a shape-memory property [J]. Biomacromolecules, 2007, 8: 2774-2780. (Pubitemid 47516929)
22. Chen MC, Chang Y, Liu CT, et al. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents [J]. Biomaterials, 2009, 30: 79-88.
23. Thierry B, Kujawa P, Tkaczyk C, et al. Delivery platform for hydrophobic drugs: prodrug approach combined with self-assembled multilayers [J]. J Am Chem Soc, 2005, 127: 1626-1627. (Pubitemid 40229134)
24. Lin KQ, Ding X, Qiu FY, et al. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer [J]. Biomaterials, 2010, 31: 4017-4025.
25. Takahashi A, Palmer-Opolski M, Smith RC, et al. Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent [J]. Gene Ther, 2003, 10: 1471-1478. (Pubitemid 36987141)
26. Kang E, Vedantham K, Long X, et al. Drug-eluting stent for delivery of signal pathway-specific 1, 3-dipropyl-8-cyclopentyl xanthine [J]. Mol Pharm, 2009, 6: 1110-1117.
27. Beusekom HMM, Whelan DM, Krabbendam SC, et al. Biocompatibility of phosphorylcholine coated stents in a porcine coronary model [J]. Circulation, 2000, 83: 338-345. (Pubitemid 30313341)
28. Chan KH, Armstrong J, Withers S, et al. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents [J]. Biomaterials, 2007, 28: 1218-1224. (Pubitemid 44816381)
29. Lewis AL, Tolhurst, LA, Stratford PW. Analysis of a phosphorylcholine- based polymer coating on a coronary stent pre- and post-implantation [J]. Biomaterials, 2002, 23: 1697-1706. (Pubitemid 34158593)
30. Chim YTA, Lam J KW, Ma Y, et al. Structural study of DNA condensation induced by novel phosphorylcholine-based copolymers for gene delivery and relevance to DNA protection [J]. Langmuir, 2005, 21: 3591-3598. (Pubitemid 40538371)
31. Windecker SH, Meier B. Late coronary stent thrombosis [J]. Circulation, 2007, 116: 1952-1965. (Pubitemid 350287091)
32. Pan CJ, Tang JJ, Weng YJ, et al. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents [J]. Colloids Surf B Biointerfaces, 2009, 73: 199-206.
33. Pan CJ, Tang JJ, Weng YJ, et al. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents [J]. J Control Release, 2006, 116: 42-49. (Pubitemid 44792298)
34. Xi TF, Gao RL, Xu B, et al. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents [J]. Biomaterials, 2010, 31: 5151-5158.
35. Pan CJ, Wang J, Huang N. Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings [J]. Colloids Surf B Biointerfaces, 2010, 77: 155-160.
36. Unger F, Westedt U, Hanefeld P, et al. Polyethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? [J]. J Control Release, 2007, 117: 312-321. (Pubitemid 46216577)
37. Steigerwald K, Merl S, Kastrati A, et al. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts [J]. Biomaterials, 2009, 30: 632-637.
38. Gultepe E, Nagesha D, Sridhar S, et al. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices [J]. Adv Drug Deliv Rev, 2010, 62: 305-315.
39. 2 nanotubes on vascular cells [J]. Nano Lett, 2010, 10: 143-148.
40. 2 nanotubes on endothelial function and smooth muscle proliferation [J]. Biomaterials, 2009, 30: 1268-1272.
41. 2 nanotubes [J]. Nano Lett, 2009, 9: 1932-1936.
42. Sotirovska N, Birtles J, Colley K, et al. Sol-gel silica, polymer free, bioabsorbable coating for delivery of paclitaxel from stent [J]. Cardiovasc Revasc Med, 2009, 10: 259-260.
43. Ma XQ, Yu ZT, Hu T, et al. Preparation and biological effect of Fe/Pd magnetic film on vascular stent surface [J]. Rare Metal Mater Engin, 2010, 39: 949-952.
44. Hu T, Yu ZT, Zhou L, et al. The effect of superficial magnetic films of 316L medical steel stents on endothelialization [J]. Rare Metal Mater Engin, 2009, 38: 1552-1555.
45. Hu T, Li ZX, Ma XQ, et al. Deposition of (Fe/Pd)(n) film on medical 316L stainless steel stent surface [J]. Rare Metal Mater Engin, 2009, 38: 1437-1440.
46. Lvov Y, Decher G, Sukhorukov G. Assembly of thin-films by means of successive deposition of alternate layers of DNA and poly(Allylamine) [J]. Macromolecules, 1993, 26: 5396-5399.
47. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries [J]. Nat Biotechnol, 2000, 18: 1181-1184.
48. Chen MC, Liang HF, Chiu YL, et al. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus [J]. J Control Release, 2005, 108: 178-189.
49. Gong F, Cheng XY, Wang SF, et al. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents [J]. Acta Biomaterialia, 2010, 6: 534-546.
50. Lahann J, Klee D, Pluester W, et al. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices [J]. Biomaterials, 2001, 22: 817-826. (Pubitemid 32143795)
51. Freitas SC, Barbosa MA, Martins CL. The effect of immobilization of thrombin inhibitors onto self-assembled monolayers on the adsorption and activity of thrombin [J]. Biomaterials, 2010, 31: 1-9.
52. Cho JC, Cheng G, Feng D, et al. Characterization, properties, and drug release of poly(alkylmethacrylate-b-isobutylene-b-alkyl methacrylate) [J]. Biomacromolecules, 2006, 7: 2997-3007.
53. Okner R, Shaulov Y, Tal N, et al. Electropolymerized tricopolymer based on N-pyrrole derivatives as a primer coating for improving the performance of a drug-eluting stent [J]. App Mater Interf, 2009, 1: 758-767.
54. Nukala RK, Boyapally H, Slipper IJ, et al. The application of electrostatic dry powder deposition technology to coat drug-eluting stents [J]. Pharm Res, 2010, 27: 72-81.